Which has grown faster, BMRN or TXG?

Over the past five years, BMRN grew revenue faster — BMRN at a 12.19% CAGR versus TXG at 8.74%.

Is BMRN or TXG more profitable?

BMRN runs the higher net margin — BMRN at 2.14% versus TXG at -12.18%.

How have BMRN and TXG total returns compared?

Over the past 5 years, BMRN delivered -5.59% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

BioMarin Pharmaceutical Inc. (BMRN) vs 10x Genomics, Inc. (TXG)

A side-by-side comparison of BioMarin Pharmaceutical Inc. and 10x Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BMRN

BioMarin Pharmaceutical Inc.

$10.87B

$56.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TXG

10x Genomics, Inc.

$10.24B

$80.66HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BMRN vs TXG

growth of $100 · dividends reinvested · last 7y

BMRN -20.2% (-3.2%/yr)TXG +85.3% (+9.2%/yr)TXG compounded faster over this window

BMRN TXG

BMRN vs TXG: by the numbers

•BMRN is the larger company ($10.87B vs $10.24B market cap).
•BMRN is profitable (2.14% net margin) while TXG runs a net loss (-12.18%).
•BMRN grew revenue faster over the past five years (12.19% vs 8.74% CAGR).

Metrics side by side

Valuation

Metric	BMRN	TXG
P/E ratio	144.15	N/A
P/S ratio	3.19	16.60
P/B ratio	1.72	12.40
EV / EBITDA	33.30	N/A
FCF yield	6.74%	1.19%

Profitability

Metric	BMRN	TXG
Gross margin	75.55%	70.03%
Operating margin	16.56%	-14.33%
Net margin	2.14%	-12.18%
ROE	1.15%	-9.10%
ROIC	1.40%	-9.57%

Growth (annualized)

Metric	BMRN	TXG
Revenue CAGR (5Y)	12.19%	8.74%
EPS CAGR (5Y)	-17.46%	N/A
FCF CAGR (5Y)	33.84%	N/A
Total return CAGR (5Y)	-5.59%	-7.24%

Frequently asked

Which has grown faster, BMRN or TXG?: Over the past five years, BMRN grew revenue faster — BMRN at a 12.19% CAGR versus TXG at 8.74%.
Is BMRN or TXG more profitable?: BMRN runs the higher net margin — BMRN at 2.14% versus TXG at -12.18%.
How have BMRN and TXG total returns compared?: Over the past 5 years, BMRN delivered -5.59% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMRN analysis Full TXG analysis Interactive comparison tool

Dig into the metrics

BioMarin Pharmaceutical P/E ratio BioMarin Pharmaceutical ROE 10x Genomics ROE BioMarin Pharmaceutical operating margin 10x Genomics operating margin BioMarin Pharmaceutical revenue growth 10x Genomics revenue growth BioMarin Pharmaceutical free cash flow 10x Genomics free cash flow

BioMarin Pharmaceutical & 10x Genomics appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.